2022956-71-2
Chemical Structure
(Lys(Me)34)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide
- CAS No.: 2022956-71-2
- Formula:C117H212N43O32S+
- Molecular Weight:2765.27
SMILES: O=C([C@H]1N(CCC1)C([C@H](C)NC([C@H](CCCCN)NC(CNC(CNC([C@H]([C@H](O)C)NC([C@H](CO)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC([C@H](C)NC([C@H]([C@H](O)C)NC([C@H](CCC(N)=O)NC([C@H](CCCC[N+](C)(C)C)NC([C@H]([C@H](O)C)NC([C@@H](NC([C@@H](N)C)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(NCC(NCC(N[C@H](C(N)=O)CCCCNC(CCCC[C@H]2[C@]3([H])[C@](NC(N3)=O)([H])CS2)=O)=O)=O)=O)=O)=O)=O)=O.O=C([C@H]4N(CCC4)C([C@H](C)NC([C@H](CCCCN)NC(CNC(CNC([C@H]([C@H](O)C)NC([C@H](CO)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC([C@H](C)NC([C@H]([C@H](O)C)NC([C@H](CCC(N)=O)NC([C@H](CCCC[N+](C)(C)C)NC([C@H]([C@H](O)C)NC([C@@H](NC([C@@H](N)C)=O)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(NCC(NCC(N[C@H](C(N)=O)CCCCNC(CCCC[C@H]5[C@]6([H])[C@](NC(N6)=O)([H])CS5)=O)=O)=O)=O)=O)=O)=O)=O
Biological Activity: (Lys(Me)34)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Lys(Me)34)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide | (Lys(Me)34)-Histone H3 (1-21)-Gly-Gly-Lys(biotinyl) amide is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||